Seminars in Liver Disease

Papers
(The median citation count of Seminars in Liver Disease is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
70
Mesenchymal Stem Cell Transplantation in Liver Diseases63
59
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns46
Erratum to: Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics41
Biomarker Development Using Liquid Biopsy in Hepatocellular Carcinoma35
Beyond Varices: Complications of Cirrhotic Portal Hypertension in Pediatrics32
Influence of Sex in the Development of Liver Diseases29
NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?28
Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD25
Novel Biomarkers of AKI in Cirrhosis22
Emerging Roles of Spatial Transcriptomics in Liver Research20
Post-Transplant Biliary Strictures: An Updated Review19
Statins in Chronic Liver Disease: Review of the Literature and Future Role19
Surrogate Markers for Hepatitis B Virus Covalently Closed Circular DNA19
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD19
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?18
Recent Advances in Intrahepatic Biliary Epithelial Heterogeneity18
Gestational and Developmental Contributors of Pediatric MASLD16
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future16
16
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma15
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol14
Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine13
Management of Portal vein Thrombosis in Cirrhosis13
Mast Cell and Innate Immune Cell Communication in Cholestatic Liver Disease13
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype11
Management of Multidrug-Resistant Infections in Cirrhosis11
UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis11
Hepatocellular Carcinoma Chemoprevention with Generic Agents11
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?11
Immune Checkpoint Inhibitor-Induced Liver Injury10
Artificial Intelligence in Hepatology: A Narrative Review10
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease10
Environmental Pollutants, Occupational Exposures, and Liver Disease10
10
Role of Lipogenesis Rewiring in Hepatocellular Carcinoma10
Blinding in Clinical Trials for Chronic Liver Diseases10
Hepatitis Delta Infection: A Clinical Review9
The Neglected Role of Bile Duct Epithelial Cells in NASH9
Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment8
Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review8
Endoscopic Advances in Hepatology8
Corrigendum: Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future8
Role of Biliary Organoids in Cholestasis Research and Regenerative Medicine8
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease8
Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure8
The Changing Epidemiology of Alcohol-Associated Liver Disease: Gender, Race, and Risk Factors8
Early Diagnosis and Prevention of Infections in Cirrhosis7
Genetic and Epigenetic Basis of Drug-Induced Liver Injury7
HBV Biomarkers and Their Role in Guiding Treatment Decisions7
Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective7
Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update7
Biliary Tract Cancer: Molecular Biology of Precursor Lesions7
Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration6
6
Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency6
Liver Dysfunction in COVID-19: From Onset to Recovery6
6
6
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics5
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis5
Hepatic Alveolar Echinococcosis5
Hepatitis B Core-Related Antigen: From Virology to Clinical Application5
Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment5
Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations5
Role of Neutrophils in the Development of Steatotic Liver Disease4
Mastering Core Recommendations during HEPAtology ROUNDS in Patients with Advanced Chronic Liver Disease4
Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective4
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease4
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy4
4
Erratum to: Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy4
GAS6/TAM Axis as Therapeutic Target in Liver Diseases4
Erratum to: Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis3
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease3
LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology3
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms3
Pathogenesis and Management of Intestinal Failure-Associated Liver Disease3
Involvement of Epigenomic Factors in Bile Duct Cancer3
Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease3
Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution3
The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone3
Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer3
Research Progress on the Role and Mechanism of IL-37 in Liver Diseases2
Cirrhosis Management in the Intensive Care Unit2
Managing Multiorgan Failure in Acute on Chronic Liver Failure2
Alcohol-Related Liver Disease: Is There a Safe Alcohol Consumption Limit for Liver Disease?2
Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD2
Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy2
Wilson Disease: Novel Diagnostic and Therapeutic Approaches2
Role of YAP1 Signaling in Biliary Development, Repair, and Disease2
Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis2
Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?2
Mice Engrafted with Human Liver Cells2
Gallstones: Prevention, Diagnosis, and Treatment2
Physiomimetic In Vitro Human Models for Viral Infection in the Liver2
0.12542295455933